Valeo Financial Advisors, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,728
-85.0%
14,825
-2.3%
0.00%
-100.0%
Q2 2023$18,132
+72.9%
15,1730.0%0.00%0.0%
Q1 2023$10,488
+1.8%
15,1730.0%0.00%0.0%
Q4 2022$10,302
-31.3%
15,173
+2.3%
0.00%0.0%
Q3 2022$15,000
+50.0%
14,8250.0%0.00%0.0%
Q2 2022$10,000
-33.3%
14,825
+394.2%
0.00%0.0%
Q1 2021$15,0003,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders